The national outcry over escalating drug prices has rather swiftly turned into the stuff of legislation as, in the election year, elected officials are demonstrating their concerns over the unseemly price hikes.

Case in point: the CREATES Act. The acronym stands for Creating and Restoring Equal Access to Equivalent Samples — in this case, an acronym that says what the bill actually is.

As reported by Modern Healthcare, this bill with bipartisan Congressional support and consumer group/labor union backing would force brand-name drug companies to play nicer with the makers of generics. The prices of many generics has spiked of late, the cause of much of the complaining about drug prices. The generic makers claim much of the blame can be placed on the brand-name makers and the barriers they have erected to quickly releasing generic versions once patents expire.

Continue Reading for Free

Register and gain access to:

  • Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Dan Cook

Dan Cook is a journalist and communications consultant based in Portland, OR. During his journalism career he has been a reporter and editor for a variety of media companies, including American Lawyer Media, BusinessWeek, Newhouse Newspapers, Knight-Ridder, Time Inc., and Reuters. He specializes in health care and insurance related coverage for BenefitsPRO.